An interventional study of Calming Touch in Dementia and Agitation,Psychomotor, sponsored by University College Copenhagen. Completed at 1 site in Denmark. Per ClinicalTrials.gov, last updated 2023-09-07.
Sponsored by University College Copenhagen · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 30 studies in Dementia with a site in Denmark — 6 open to participants now, 12 under way, 1 of them phase 3. Dementia · Denmark.
Among the 30 studies in Dementia with a site in Denmark, this one is the 21st largest by enrollment of the 21 interventional ones that give a count, is one of 4 that started in 2021, is one of 10 with no phase, and was the 17th registered.
2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.
Browse Dementia studies →6 of the 30 studies in Dementia with a site in Denmark are open now. Recruiting first, the newest first:
Aarhus University Hospital · Sites in Denmark, Germany, Norway and 2 more countries
Ages 50+
University of Southern Denmark · Sites in Denmark
Ages 65+
Aarhus University Hospital · Sites in Denmark
Ages 60+
Zealand University Hospital · Sites in Denmark
Ages 50+ · Healthy volunteers
Center for Clinical Research and Prevention · Sites in Denmark
Ages 18+ · Healthy volunteers
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
30 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 5 · Phase 3 5 · Phase 4 2
First in 2003; this study’s year is marked. 4 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 20 is below the median of 90 across 1,761 interventional studies indexed under Dementia.
Median enrollment 339 across the 21 interventional studies, 140 across the 9 observational. Of the 17 that completed or were terminated, 5 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 30 have an industry lead sponsor. The 10 most frequent:
University College Copenhagen is the lead sponsor of 8 studies on the registry; 4 are open to participants now.
University College Copenhagen has 1 study filed under Dementia — fewer than ten, so there is no comparison to draw.
3 of the studies in Dementia with a site in Denmark that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06624267University Hospital Bispebjerg and FrederiksbergTest of Reproducibility of [15O]H20-PET Assessment of Brain Perfusion | 2027-01 |
| NCT06451692University of Southern DenmarkPrioritising Patient Medication Review: Hospitals Reaching Out | 2027-01-01 |
| NCT07741526Arctic TherapeuticsSafety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects With MCI or Alzheimer's Disease (AD) | 2027-04-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 30 studies in Dementia with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Dementia is an increasing health challenge among elderly citizens in Denmark. An estimated 87,000 Danes live with dementia, and this number is expected to increase to 130,000 in 2030. Psychiatric symptoms and behavioral changes decrease quality of life for patients and their spouses and is a challenge for caretakers. Behavior changes include agitation which can be divided in four sub-groups: 1) physical aggression, 2) physical non-aggression, 3) verbal aggression, and 4) verbal non-aggression. Pharmaceutical management of behavioral changes is common and may be associated with negative side-effects including drowsiness and falls. Though non-pharmaceutical interventions such as music, massage and social activities have been recommended the underlying evidence is limited. In this randomized feasibility trial, we will investigate the feasibility and acceptability of therapeutic touch aiming to reduce agitated behavior in people living with dementia in a nursing home that specializes in the care of people living with severe dementia.
The success criteria of this randomized feasibility trial are as follows:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The calming treatment consists of deep pressure massage and gentle facilitation. The therapist works with the vertical axis, center, respiration, body boundaries and the feet.
Behavioral: Calming Touch
The usual care group may participate in usual activities at the nursing home e.g. physio- and occupational therapy, listening to calming music, holdning hands with care-takers.
The calming treatment consists of deep pressure massage and gentle facilitation. The therapist works with the vertical axis, center, respiration, body boundaries and the feet.
Change in Cohen-Mansfield Agitation Inventory (CMAI) from baseline to 4, 8, and 12 weeks after baseline.
The Cohen-Mansfield Agitation Inventory (CMAI; Cohen-Mansfield, 1986) is a 29-item questionnaire designed to measure the types and frequencies of agitated behaviors exhibited by elderly nursing home residents
Time frame: CMAI will be performed 2 weeks before baseline, at baseline, and 4, 8, and 12 weeks post baseline.
The Erlangen Test for Activities of Daily Living (E-ADL-Test)
The Erlangen Test of Activities of Daily Living (E-ADL-Test) consists of five items: pouring a drink, cutting a piece of bread, opening a small cupboard, washing hands and tying a bow. Each test item underwent standardized evaluation on a scale of 0 to 6.
Time frame: The E-ADL-Test will be performed at baseline, and 4, 8, and 12 weeks post baseline.
Hair cortisol levels
Hair samples will be collected and cortisol levels will be analyzed
Time frame: Hair samples will be collected at baseline, and 4, 8, and 12 weeks post baseline.
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2021 to primary completion in Dec 2022, 14 months.
Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's 14 months is below that.
Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University College Copenhagen